{"id":"W1990025047","doi":"10.1161/circulationaha.113.005081","title":"Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus","year":2013,"lang":"en","type":"article","venue":"Circulation","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1307,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"American Diabetes Association","keywords":"Empagliflozin; Medicine; Renal function; Glomerular hyperfiltration; Internal medicine; Effective renal plasma flow; Endocrinology; Renal blood flow; Diabetes mellitus; Tubuloglomerular feedback; Plasma renin activity; Aldosterone; Filtration fraction; Type 2 diabetes; Urology; Renin–angiotensin system; Blood pressure; Diabetic nephropathy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003918426627373016,"score_gpt":0.1937316932782741,"score_spread":0.1898132666509011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}